Journal article
Does incarceration influence patients' goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail
Drug and alcohol dependence, Vol.222, pp.108529-108529
05/01/2021
DOI: 10.1016/j.drugalcdep.2021.108529
PMCID: PMC10044474
PMID: 33810909
Abstract
Background: Correctional facilities increasingly offer medications for opioid use disorder (OUD), including buprenorphine. Nevertheless, retention in treatment post-incarceration is suboptimal and overdose mortality remains high. Our objectives were to understand how incarcerated patients viewed buprenorphine treatment and identify modifiable factors that influenced treatment continuation post-release.
Methods: We conducted semi-structured interviews with 22 men receiving buprenorphine treatment in an urban jail. Interviews were audio recorded, professionally transcribed, and analyzed using a grounded-theory approach. Team members constructed preliminary case memos from transcripts, and then interactively discussed themes within respective memos. We established participant 'typologies' by consensus.
Results: Distinct typologies emerged based on participants' post-release treatment goals: (1) those who viewed buprenorphine treatment as a cure for OUD; (2) those who thought buprenorphine would help manage opioid-related problems; and (3) those who did not desire OUD treatment. Participants also described common social structural barriers to treatment continuation and community re-integration. Participants reported that post-release housing instability, unemployment, and negative interactions with parole contributed to opioid use relapse and re-incarceration.
Conclusion: Participants had different goals for post-release buprenorphine treatment continuation, but their prior experiences suggested that social structural issues would complicate these plans. Incarceration can intensify marginalization, which when combined with heightened legal supervision, reinforced cycles of release, relapse, and re-incarceration. Participants valued buprenorphine treatment, but other structural and policy changes will be necessary to reduce incarceration-related inequities in opioid overdose mortality.
Details
- Title: Subtitle
- Does incarceration influence patients' goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail
- Creators
- William Vail - Albert Einstein College of MedicineElissa Faro - Albert Einstein College of MedicineDana Watnick - Albert Einstein College of MedicineJonathan Giftos - Correctional Health Services, NYC Health + Hospitals, United States.Aaron D. Fox - Albert Einstein College of Medicine
- Resource Type
- Journal article
- Publication Details
- Drug and alcohol dependence, Vol.222, pp.108529-108529
- DOI
- 10.1016/j.drugalcdep.2021.108529
- PMID
- 33810909
- PMCID
- PMC10044474
- NLM abbreviation
- Drug Alcohol Depend
- ISSN
- 0376-8716
- eISSN
- 1879-0046
- Publisher
- Elsevier
- Number of pages
- 6
- Grant note
- UL1TR002556-01 / National Center for Advancing Translational Sciences (NCATS), components of the National Institutes of Health (NIH), through CTSA NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA NIDDK; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) NIAID; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID) NHLBI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI) P30-AI124414 / Einstein-Rockefeller-CUNY Center for AIDS Research NICHD; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) NIMH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH) NCI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) NIMHD FIC NIA; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA) NIGMS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS) NIDA; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)
- Language
- English
- Date published
- 05/01/2021
- Academic Unit
- General Internal Medicine; Internal Medicine
- Record Identifier
- 9984359858402771
Metrics
14 Record Views